Matthew B McNeil

9PUBLICATIONS
46CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Soil biologySpeciation and extinctionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 13, 2026
Dual inhibition of respiratory complexes in <i>Mycobacterium tuberculosis</i> results in bacterial killing.

|Jun 05, 2026
Genome scale CRISPRi reveals both shared and strain-specific vulnerabilities in genetically diverse drug-resistant strains of Mycobacterium tuberculosis.

|Jun 02, 2026
Aerobic soil bacteria adapt to hypoxia by hybridizing fermentation with carbon storage.

|Apr 13, 2026
Dormancy regulon reduction was pivotal to the evolution of Mycobacterium tuberculosis.

Matthew Silcocks, James P Lingford, Chen-Yi Cheung

|Jan 29, 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis.

Isabel K Barter, Max J Bedding, Julia Leodolter

|Apr 17, 2025
Verapamil and its metabolite norverapamil inhibit the <i>Mycobacterium tuberculosis</i> MmpS5L5 efflux pump to increase bedaquiline activity.

Adam J Fountain, Natalie J E Waller, Chen-Yi Cheung

Pageof 2

Frequent Collaborators

7 joint publications

Gregory M Cook

2 joint publications

XinYue Wang

2 joint publications

Peter C Fineran

2 joint publications

Simon A Jackson